Description
Selank is a synthetic heptapeptide developed in Russia, used as a fast-acting anxiolytic and nootropic. Typically administered subcutaneously, it is reported to modulate GABAergic activity and cytokine metabolism, supporting reduced anxiety, improved mood and cognitive functions (memory, learning) with anxiolysis without marked sedation and a favorable tolerability profile in available preclinical and clinical studies.
Key features
- Composition: Selank (heptapeptide; N-terminal analogue of tuftsin)
- Mechanism: indirect modulation of the GABAergic system, regulation of the
neuro-immune-endocrine axis, and influence on neurotransmitter metabolism
(e.g., increased serotonin availability) - Route: subcutaneous injection
- Presentation: vial for reconstitution
- Symptomatic management of anxiety and stress-related states
- Adjunctive support for cognition, attention, memory and functional recovery in
selected, supervised contexts
Customer benefits:
- Rapid reduction of anxiety with minimal sedation
- Potential improvement in mood, attention and memory performance
- Good tolerability and low abuse potential compared with benzodiazepines
| Before reconstitution: | After reconstitution: |
|---|---|
| -Temperature: generally -20 °C (frozen) -Protect from light and moisture; keep vial tightly closed -Avoid repeated freeze/thaw cycles |
-Temperature: usually 2-8°C, protected from light -Do not freeze the reconstituted solution |


Reviews
There are no reviews yet.